Myo-inositol and D-chiro-inositol enhance insulin receptor sensitivity and reduce hyperandrogenism in PCOS. Clinical trials show improved ovulatory function, metabolic parameters, and fertility outcomes. Inositol may serve as a first-line adjunctive treatment, especially in insulin-resistant phenotypes.